Application of progenitor niche signals to EX vivo nephrogenesis - specific aims there are more than 100K american waiting for a kidney transplant, but demand far exceeds supply
Active Project Grant Awarded Last action
- Award ID
- RC2DK125960
- Recipient
-
The Rogosin Institute Inc. UEI RNFSMT79DVD4
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,617,822
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date 88% complete
- Originally
- Funding
-
- $12,094,330.21 Federal
- $1,523,492.00 Non-federal
- Place of performance
- New York, NY 10065, USA
Award details come from USAspending.gov.
Description
EX vivo organogenesis is a potential source for functional tissue for renal replacement therapy. We and others established techniques to generate cellularly complex kidney organoids from human induced pluripotent cells (ipscs). Theoretically, ipsc-derived renal organoids would be grafted to host tissue and would integrate with vascular and urinary systems to supplement lost kidney function. However, data indicates that implanted organoids integrate poorly with the host kidney. Based on experimental observations, we identified at least 3 key obstacles that must be overcome to generate integrated renal organoids (FIG. 1): tissue organization: organoid tubules, blood vessels, and stroma lack cortico-medullary pattern. Tubular fusion: with current strategies, organoid tubules and vessels do not anastomose with host tissues. Functional assays: we lack assays to identify successful renal replacement by organoid tissue. The goal of our collaborative team is to generate the tools, reagents and protocols to overcome each of these obstacles. In our recent studies, we discovered the following: 1) distinct stromal cell populations are required to establish correct zonal organization and segment-specific differentiation of tubules and vasculature; 2) organoids lack a normal distribution and complement of stromal cell populations; 3) stromal cells and their secreted products can facilitate tubule-tubule interconnection. These findings show that formation of renal organoids that are appropriately patterned for in vivo function depends on creating the correct complement and organization of stromal cells. The concept that anatomically "correct" tissue that is matched to the engraftment site can be generated through manipulation of stromal cell populations is novel and identifies a GAP in our understanding of stromal cell biology of developing kidney tissue. To fill this GAP and generate resources to determine how this novel patterning mechanism can be exploited to generate kidney tissue for renal replacement, we propose a series of hypothesis-generating investigations that will define the roles of diverse stromal cells in patterning the vasculature and renal epithelium as well as promoting tubular connection to the host. Our longterm goal is to generate functional proximal nephrons with appropriately patterned microvasculature that integrate with the host urinary and circulatory systems for functional renal replacement. To facilitate our efforts to promote tubule and vascular fusion, we will develop a pipeline for in vivo testing of laboratory-derived tissue in animals with impaired kidney function. In preliminary data, we demonstrate novel functional assays including elisas and live imaging of tubular fluid flow that can rapidly and easily assess the contribution of implanted organoids to host urine production. We will also generate novel resources, including stromal cell lines, reporter mice, imaging technology, and assays to quantify the extent of renal replacement by organoid tissue. We propose the following aims: aim 1: develop strategies to modulate organoid stroma to promote proximal nephron segments 1A. Develop protocols to promote formation of proximal tubule stroma. 1B. Investigate the role of macrophages in organoid differentiation. Aim 2. Generate robust and functionally regionalized renal vasculature in tissue grafts 2A. Evaluate vascular maintenance, growth, and recruitment in organoids. 2B. Characterize stromal impact on organoid vasculature. 2C. Generate "vascular-primed" organoids. Aim 3. Identify strategies to promote tubule fusion in renal epithelia 3A. Identify the role of stromal interactions on epithelial tubule anastomosis. 3B. Determine the role of HGF and tgfss on tubule anastomosis in organoids. Aim 4. Evaluate function of graft tiss
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $1,403,957 | $0 | |
| Amendment | $1,442,245 | $0 | |
| Amendment | $161,706 | $0 | |
| Amendment | $1,507,353 | $0 | |
| Amendment | $1,507,353 | $0 | |
| Amendment | $1,512,366 | $0 | |
| Amendment | $1,512,366 | $0 | |
| Amendment | $1,523,492 | $0 | |
| Original award | $1,523,492 | $1,523,492 |
Quick answers
Who received award RC2DK125960?
RC2DK125960 was awarded to The Rogosin Institute Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 15, 2021.
How much is award RC2DK125960 worth?
$13,617,822 has been obligated on RC2DK125960: $12,094,330 in federal funding and $1,523,492 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award